laitimes
return

U.S. stock market movements | Cassava Sciences(SAVA. US) pre-hours rise more than 8% The FDA rejects a citizen petition applying for a moratorium on drug trials for Alzheimer's disease

Zhitong Finance APP learned that before the US stock market on February 11 (Friday), as of press time, Cassava Sciences (SAVA. US) rose 8.01 percent at $57.3. On the news side, the U.S. Food and Drug Administration (FDA) rejected a citizens' petition to suspend a key trial of Cassava Sciences' Alzheimer's drug simufilam.

citizen Time out drugs trial
Previous: [The new houses in the countryside are beautiful, but the young people have gone to the city, is this also the case in your hometown? Now this phenomenon is in many places, and rural houses are very well built, but they are not
Next: Cassava Sciences(SAVA. US) followed by more than 7% the FDA rejected a citizen petition to suspend drug trials for Alzheimer's disease

Read on